BACKGROUND AND PURPOSE: The purposes of this study were to determine the incidence of neurovascular events as late complications in pediatric patients with brain tumor and to evaluate radiation as a risk factor. METHODS: Patients were ascertained using the tumor database of a pediatric tertiary care center. Included patients had a primary brain tumor, age birth to 21 years, initial treatment January 1, 1993, to December 31, 2002, and at least 2 visits with neuro-oncology. Radiation exposure included: whole brain, whole brain plus a focal boost, or focal brain. The primary outcome was stroke or transient ischemic attack. RESULTS: Of 431 subjects, 14 had 19 events of stroke or transient ischemic attack over a median follow-up of 6.3 years. The incidence rate was 548/100 000 person-years. Overall, 61.5% of subjects received radiation, including 13 of 14 subjects with events. Median time from first radiation to first event was 4.9 years. The stroke/transient ischemic attack hazard ratio for any brain irradiation was 8.0 (95% CI, 1.05-62; P=0.045); for the circle of Willis, radiation was 9.0 (95% CI, 1.2-70; P=0.035); and for focal noncircle of Willis, radiation was 3.4 (95% CI, 0.21-55; P=0.38). CONCLUSIONS: The incidence of neurovascular events in this population is 100-fold higher than in the general pediatric population and cranial irradiation is an important risk factor. By defining the incidence of this late effect, physicians are better able to counsel parents regarding treatment, monitor patients at risk, and target a population for primary stroke prevention in future studies.
BACKGROUND AND PURPOSE: The purposes of this study were to determine the incidence of neurovascular events as late complications in pediatric patients with brain tumor and to evaluate radiation as a risk factor. METHODS:Patients were ascertained using the tumor database of a pediatric tertiary care center. Included patients had a primary brain tumor, age birth to 21 years, initial treatment January 1, 1993, to December 31, 2002, and at least 2 visits with neuro-oncology. Radiation exposure included: whole brain, whole brain plus a focal boost, or focal brain. The primary outcome was stroke or transient ischemic attack. RESULTS: Of 431 subjects, 14 had 19 events of stroke or transient ischemic attack over a median follow-up of 6.3 years. The incidence rate was 548/100 000 person-years. Overall, 61.5% of subjects received radiation, including 13 of 14 subjects with events. Median time from first radiation to first event was 4.9 years. The stroke/transient ischemic attack hazard ratio for any brain irradiation was 8.0 (95% CI, 1.05-62; P=0.045); for the circle of Willis, radiation was 9.0 (95% CI, 1.2-70; P=0.035); and for focal noncircle of Willis, radiation was 3.4 (95% CI, 0.21-55; P=0.38). CONCLUSIONS: The incidence of neurovascular events in this population is 100-fold higher than in the general pediatric population and cranial irradiation is an important risk factor. By defining the incidence of this late effect, physicians are better able to counsel parents regarding treatment, monitor patients at risk, and target a population for primary stroke prevention in future studies.
Authors: S Nishizawa; H Ryu; T Yokoyama; T Ninchoji; I Shimoyama; S Yamamoto; K Uemura Journal: Neurol Med Chir (Tokyo) Date: 1991-06 Impact factor: 1.742
Authors: James G Gurney; Nina S Kadan-Lottick; Roger J Packer; Joseph P Neglia; Charles A Sklar; Judy A Punyko; Marilyn Stovall; Yutaka Yasui; H Stacy Nicholson; Suzanne Wolden; Dawn E McNeil; Ann C Mertens; Leslie L Robison Journal: Cancer Date: 2003-02-01 Impact factor: 6.921
Authors: Heather J Fullerton; Kayla Stratton; Sabine Mueller; Wendy W Leisenring; Greg T Armstrong; Rita E Weathers; Marilyn Stovall; Charles A Sklar; Robert E Goldsby; Les L Robison; Kevin R Krull Journal: Neurology Date: 2015-08-26 Impact factor: 9.910
Authors: Sarah M Kranick; Cynthia J Campen; Scott E Kasner; Sudha K Kessler; Robert A Zimmerman; Robert A Lustig; Peter C Phillips; Lauren A Beslow; Rebecca Ichord; Michael J Fisher Journal: Neurology Date: 2013-03-13 Impact factor: 9.910
Authors: Ayal A Aizer; Malak Abedalthagafi; Wenya Linda Bi; Margaret C Horvath; Nils D Arvold; Ossama Al-Mefty; Eudocia Q Lee; Lakshmi Nayak; Mikael L Rinne; Andrew D Norden; David A Reardon; Patrick Y Wen; Keith L Ligon; Azra H Ligon; Rameen Beroukhim; Ian F Dunn; Sandro Santagata; Brian M Alexander Journal: Neuro Oncol Date: 2015-08-30 Impact factor: 12.300